Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120263) titled 'Observational Study of Fosrolapitant and Palonosetron Hydrochloride for Injection for the Prevention of Treatment-Related Nausea and Vomiting in Cancer Patients' on March 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
chemotherapy-induced nausea and vomiting
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-16
Target Sample Size: Exposure group:300;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=312468
Published by HT Digital Content Services with p...